4//SEC Filing
Blackwell Kimberly 4
Accession 0001725160-24-000026
CIK 0001725160other
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 7:11 PM ET
Size
8.9 KB
Accession
0001725160-24-000026
Insider Transaction Report
Form 4
Blackwell Kimberly
Director
Transactions
- Tax Payment
Common Stock
2024-02-01$11.69/sh−20,655$241,457→ 484,145 total - Award
Common Stock
2024-02-01+250,000→ 504,800 total - Award
Stock Option (Right to Buy)
2024-02-01+250,000→ 250,000 totalExercise: $11.69Exp: 2034-01-31→ Common Stock (250,000 underlying)
Footnotes (3)
- [F1]Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a four year period following the grant date, subject to the Reporting Person's continued service with the Issuer.
- [F2]Shares automatically withheld to satisfy tax obligations upon the vesting of restricted stock units previously granted to the Reporting Person.
- [F3]The options will vest over four years in equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.
Documents
Issuer
Zentalis Pharmaceuticals, Inc.
CIK 0001725160
Entity typeother
Related Parties
1- filerCIK 0001816465
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 7:11 PM ET
- Size
- 8.9 KB